Company received yet another APPROVABLE letter! Not sure as to why but should know more next week. I believe this stock will tank today and I will be looking to buy in at the $1.70 level if it gets there. The drug works and its now a matter of the Company getting its sh*t together to iron out the labeling and manufacturing issues. Perhaps, we will see a little bounce next week when the Company issues a statement. Maybe back to the mid two's?? This in MHO might be a worthwhile gamble but I'm more wrong than right in these high risk bio stocks! 
I picked up a few bucks buying this on Friday and selling yesterday. I had a feeling that the approvable letter wasn't as big of a deal as the 50% drop indicated. If you continue to hold, good luck. I think it will be dead money for a couple of months but if they get into gear as quickly as they anticipate it may end up working out very nicely for you, a little too uncertain for my liking though.
Moving up and down the past couple of days currently trading at $2.10. Phone call scheduled with FDA I believe June 18th. This drug should be approved in the next couple of months if not the next few days. In any event, I believe more upside potential then downside in the short term. Only my opinion so do your own dd on this one.
Stock beaten down yesterday after conference call with the FDA. I still like the science and will hold until next FDA session sometime in the fall. If the stock should slide below $1.60 I will probably add as I still believe the upside potential is greater than the downside. I don't own a ton of shares so this gamble is purely speculative. Good luck with your investments and beware of the FDA.
